Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece

CompletedOBSERVATIONAL
Enrollment

455

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

April 23, 2020

Study Completion Date

April 23, 2020

Conditions
RRMS
Interventions
DRUG

Dimethyl Fumarate (DMF)

The non-interventional design allows the observation of patients in a broad range of settings reflecting routine clinical practice. All decisions on therapeutic or diagnostic procedures, treatments, management of the disease, or resource utilisation will be at the full discretion of the treating physician without interference by a sponsor or study protocol. All treatment decisions will follow the real-life treatment behaviour.

Trial Locations (1)

54636

University General Hospital AHEPA (B'), Thessaloniki

All Listed Sponsors
lead

Genesis Pharma CNS & Specialty

INDUSTRY

NCT03101735 - Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece | Biotech Hunter | Biotech Hunter